Splinter TA - Search Results

1

Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1.

van der Gaast A, Schoenmakers CH, Kok TC, Blijenberg BG, Cornillie F, Splinter TA. van der Gaast A, et al. Among authors: splinter ta. Br J Cancer. 1994 Mar;69(3):525-8. doi: 10.1038/bjc.1994.95. Br J Cancer. 1994. PMID: 7510117 Free PMC article.

2

Distinction of two different classes of small-cell lung cancer cell lines by enzymatically inactive neuron-specific enolase.

Splinter TA, Verkoelen CF, Vlastuin M, Kok TC, Rijksen G, Haglid KG, Boomsma F, van de Gaast A. Splinter TA, et al. Br J Cancer. 1992 Dec;66(6):1065-9. doi: 10.1038/bjc.1992.411. Br J Cancer. 1992. PMID: 1333786 Free PMC article.

3

Evaluation of tissue polypeptide antigen serum levels for monitoring disease activity during chemotherapy in patients with transitional carcinoma of the urinary tract.

van der Gaast A, Kirkels WJ, Blijenberg BG, Splinter TA. van der Gaast A, et al. Among authors: splinter ta. J Cancer Res Clin Oncol. 1992;118(8):626-8. doi: 10.1007/BF01211809. J Cancer Res Clin Oncol. 1992. PMID: 1517284

4

Prognostic value of serum thymidine kinase, tissue polypeptide antigen and neuron specific enolase in patients with small cell lung cancer.

van der Gaast A, van Putten WL, Oosterom R, Cozijnsen M, Hoekstra R, Splinter TA. van der Gaast A, et al. Among authors: splinter ta. Br J Cancer. 1991 Aug;64(2):369-72. doi: 10.1038/bjc.1991.309. Br J Cancer. 1991. PMID: 1654076 Free PMC article.

5

Chemotherapy as treatment of choice in extrapulmonary undifferentiated small cell carcinomas.

Van Der Gaast A, Verwey J, Prins E, Splinter TA. Van Der Gaast A, et al. Among authors: splinter ta. Cancer. 1990 Feb 1;65(3):422-4. doi: 10.1002/1097-0142(19900201)65:3<422::aid-cncr2820650308>3.0.co;2-y. Cancer. 1990. PMID: 1688727

6

Evaluation of CA19-9 serum levels for monitoring disease activity during chemotherapy of pancreatic adenocarcinoma.

Bac DJ, Kok TC, van der Gaast A, Splinter TA. Bac DJ, et al. Among authors: splinter ta. J Cancer Res Clin Oncol. 1991;117(3):263-5. doi: 10.1007/BF01625436. J Cancer Res Clin Oncol. 1991. PMID: 2033095

7

Prognostic significance of tissue polypeptide-specific antigen (TPS) in patients with advanced non-small cell lung cancer.

van der Gaast A, Schoenmakers CH, Kok TC, Blijenberg BG, Hop WC, Splinter TA. van der Gaast A, et al. Among authors: splinter ta. Eur J Cancer. 1994;30A(12):1783-6. doi: 10.1016/0959-8049(94)00214-p. Eur J Cancer. 1994. PMID: 7880606

8

Long term survival of small cell lung cancer patients after chemotherapy.

van der Gaast A, Postmus PE, Burghouts J, van Bolhuis C, Stam J, Splinter TA. van der Gaast A, et al. Among authors: splinter ta. Br J Cancer. 1993 Apr;67(4):822-4. doi: 10.1038/bjc.1993.150. Br J Cancer. 1993. PMID: 8385981 Free PMC article.

9

Correlation between changes in the tumour markers CA-M26 and CA-M29 and standard response evaluation in patients with metastatic breast cancer.

van der Gaast A, Hulshof C, Kok TC, van Loon E, Splinter TA. van der Gaast A, et al. Among authors: splinter ta. Eur J Cancer. 1993;29A(6):870-3. doi: 10.1016/s0959-8049(05)80428-9. Eur J Cancer. 1993. PMID: 8484981

10

Disease monitoring by the tumour markers cyfra 21.1 and TPA in patients with non-small cell lung cancer.

van der Gaast A, Kok TC, Kho GS, Blijenberg BG, Splinter TA. van der Gaast A, et al. Among authors: splinter ta. Eur J Cancer. 1995 Oct;31A(11):1790-3. doi: 10.1016/0959-8049(95)00342-g. Eur J Cancer. 1995. PMID: 8541102 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters